http://www.mypharma-editions.com L'Info Industrie & Politique de Santé Wed, 15 Feb 2012 14:04:44 +0000 en hourly 1 http://wordpress.org/?v=3.3.1 http://www.mypharma-editions.com/cancers-de-lenfant-des-facteurs-de-susceptibilite-genetique-dans-les-tumeurs-dewing http://www.mypharma-editions.com/cancers-de-lenfant-des-facteurs-de-susceptibilite-genetique-dans-les-tumeurs-dewing#comments Mon, 13 Feb 2012 08:59:20 +0000 morgdave http://www.mypharma-editions.com/?p=23403 http://www.mypharma-editions.com/cancers-de-lenfant-des-facteurs-de-susceptibilite-genetique-dans-les-tumeurs-dewing/feed 0 http://www.mypharma-editions.com/cancer-du-sein-la-fda-accorde-une-procedure-dexamen-prioritaire-au-pertuzumab-de-roche http://www.mypharma-editions.com/cancer-du-sein-la-fda-accorde-une-procedure-dexamen-prioritaire-au-pertuzumab-de-roche#comments Thu, 09 Feb 2012 08:30:20 +0000 morgdave http://www.mypharma-editions.com/?p=23372 http://www.mypharma-editions.com/cancer-du-sein-la-fda-accorde-une-procedure-dexamen-prioritaire-au-pertuzumab-de-roche/feed 0 http://www.mypharma-editions.com/cancer-du-sein-la-has-privilegie-le-depistage-organise http://www.mypharma-editions.com/cancer-du-sein-la-has-privilegie-le-depistage-organise#comments Fri, 03 Feb 2012 12:42:35 +0000 morgdave http://www.mypharma-editions.com/?p=23328 http://www.mypharma-editions.com/cancer-du-sein-la-has-privilegie-le-depistage-organise/feed 0 http://www.mypharma-editions.com/ab-science-annonce-de-nouveaux-resultats-cliniques-pour-masitinib http://www.mypharma-editions.com/ab-science-annonce-de-nouveaux-resultats-cliniques-pour-masitinib#comments Thu, 02 Feb 2012 09:05:11 +0000 morgdave http://www.mypharma-editions.com/?p=23309 http://www.mypharma-editions.com/ab-science-annonce-de-nouveaux-resultats-cliniques-pour-masitinib/feed 0 http://www.mypharma-editions.com/bioalliance-pharma-deux-nouvelles-etapes-cles-pour-sa-biotherapie-amep-dans-le-melanome-metastatique http://www.mypharma-editions.com/bioalliance-pharma-deux-nouvelles-etapes-cles-pour-sa-biotherapie-amep-dans-le-melanome-metastatique#comments Mon, 23 Jan 2012 17:22:09 +0000 morgdave http://www.mypharma-editions.com/?p=23158 http://www.mypharma-editions.com/bioalliance-pharma-deux-nouvelles-etapes-cles-pour-sa-biotherapie-amep-dans-le-melanome-metastatique/feed 0 http://www.mypharma-editions.com/unicancer-helene-esperou-nommee-directrice-du-projet-medico-scientifique-et-de-la-qualite http://www.mypharma-editions.com/unicancer-helene-esperou-nommee-directrice-du-projet-medico-scientifique-et-de-la-qualite#comments Mon, 23 Jan 2012 14:37:42 +0000 morgdave http://www.mypharma-editions.com/?p=23150 http://www.mypharma-editions.com/unicancer-helene-esperou-nommee-directrice-du-projet-medico-scientifique-et-de-la-qualite/feed 0 http://www.mypharma-editions.com/cancer-colorectal-linca-publie-le-bilan-de-la-campagne-mars-bleu-2011 http://www.mypharma-editions.com/cancer-colorectal-linca-publie-le-bilan-de-la-campagne-mars-bleu-2011#comments Fri, 20 Jan 2012 12:48:41 +0000 morgdave http://www.mypharma-editions.com/?p=23104 http://www.mypharma-editions.com/cancer-colorectal-linca-publie-le-bilan-de-la-campagne-mars-bleu-2011/feed 0 http://www.mypharma-editions.com/oncologie-matwin-transfere-son-premier-projet-de-recherche-a-roche http://www.mypharma-editions.com/oncologie-matwin-transfere-son-premier-projet-de-recherche-a-roche#comments Tue, 10 Jan 2012 17:54:17 +0000 morgdave http://www.mypharma-editions.com/?p=22969 http://www.mypharma-editions.com/oncologie-matwin-transfere-son-premier-projet-de-recherche-a-roche/feed 0 http://www.mypharma-editions.com/cancer-deux-nouveaux-rapports-de-linca-sur-les-tests-de-genetique http://www.mypharma-editions.com/cancer-deux-nouveaux-rapports-de-linca-sur-les-tests-de-genetique#comments Tue, 10 Jan 2012 13:35:15 +0000 morgdave http://www.mypharma-editions.com/?p=22955 http://www.mypharma-editions.com/cancer-deux-nouveaux-rapports-de-linca-sur-les-tests-de-genetique/feed 0 http://www.mypharma-editions.com/lymphome-larc-et-linca-financent-un-essai-clinique-evaluant-une-nouvelle-therapie-ciblee http://www.mypharma-editions.com/lymphome-larc-et-linca-financent-un-essai-clinique-evaluant-une-nouvelle-therapie-ciblee#comments Tue, 03 Jan 2012 17:03:35 +0000 morgdave http://www.mypharma-editions.com/?p=22908 http://www.mypharma-editions.com/lymphome-larc-et-linca-financent-un-essai-clinique-evaluant-une-nouvelle-therapie-ciblee/feed 0 http://www.mypharma-editions.com/recherche-clinique-10-centres-de-lutte-contre-le-cancer-labellises http://www.mypharma-editions.com/recherche-clinique-10-centres-de-lutte-contre-le-cancer-labellises#comments Thu, 22 Dec 2011 10:21:24 +0000 morgdave http://www.mypharma-editions.com/?p=22870 http://www.mypharma-editions.com/recherche-clinique-10-centres-de-lutte-contre-le-cancer-labellises/feed 0 http://www.mypharma-editions.com/la-diversite-genetique-cruciale-pour-notre-pharmacopee http://www.mypharma-editions.com/la-diversite-genetique-cruciale-pour-notre-pharmacopee#comments Tue, 20 Dec 2011 09:07:11 +0000 morgdave http://www.mypharma-editions.com/?p=22826 http://www.mypharma-editions.com/la-diversite-genetique-cruciale-pour-notre-pharmacopee/feed 0 http://www.mypharma-editions.com/cancers-365-000-nouveaux-cas-en-france-en-2011 http://www.mypharma-editions.com/cancers-365-000-nouveaux-cas-en-france-en-2011#comments Mon, 19 Dec 2011 15:42:54 +0000 morgdave http://www.mypharma-editions.com/?p=22821 http://www.mypharma-editions.com/cancers-365-000-nouveaux-cas-en-france-en-2011/feed 0 http://www.mypharma-editions.com/roche-recoit-un-avis-favorable-du-chmp-pour-zelboraf http://www.mypharma-editions.com/roche-recoit-un-avis-favorable-du-chmp-pour-zelboraf#comments Fri, 16 Dec 2011 13:38:16 +0000 morgdave http://www.mypharma-editions.com/?p=22799 http://www.mypharma-editions.com/roche-recoit-un-avis-favorable-du-chmp-pour-zelboraf/feed 0 http://www.mypharma-editions.com/biotherapies-transgene-et-la-ligue-nationale-contre-le-cancer-signent-un-partenariat http://www.mypharma-editions.com/biotherapies-transgene-et-la-ligue-nationale-contre-le-cancer-signent-un-partenariat#comments Fri, 16 Dec 2011 09:33:46 +0000 morgdave http://www.mypharma-editions.com/?p=22795 http://www.mypharma-editions.com/biotherapies-transgene-et-la-ligue-nationale-contre-le-cancer-signent-un-partenariat/feed 0 http://www.mypharma-editions.com/essai-clinique-un-nouveau-traitement-cible-pour-les-synovialo-sarcomes http://www.mypharma-editions.com/essai-clinique-un-nouveau-traitement-cible-pour-les-synovialo-sarcomes#comments Thu, 15 Dec 2011 17:21:10 +0000 morgdave http://www.mypharma-editions.com/?p=22787 http://www.mypharma-editions.com/essai-clinique-un-nouveau-traitement-cible-pour-les-synovialo-sarcomes/feed 0 http://www.mypharma-editions.com/metastases-une-proteine-ouvre-de-nouvelles-perspectives-therapeutiques http://www.mypharma-editions.com/metastases-une-proteine-ouvre-de-nouvelles-perspectives-therapeutiques#comments Wed, 14 Dec 2011 08:55:28 +0000 morgdave http://www.mypharma-editions.com/?p=22752 http://www.mypharma-editions.com/metastases-une-proteine-ouvre-de-nouvelles-perspectives-therapeutiques/feed 0 http://www.mypharma-editions.com/cancer-colorectal-decouverte-dun-gene-protecteur http://www.mypharma-editions.com/cancer-colorectal-decouverte-dun-gene-protecteur#comments Tue, 13 Dec 2011 09:24:24 +0000 morgdave http://www.mypharma-editions.com/?p=22712 http://www.mypharma-editions.com/cancer-colorectal-decouverte-dun-gene-protecteur/feed 0 http://www.mypharma-editions.com/deux-nouveaux-guides-ald-patients-sur-la-leucemie-lymphoide-chronique-et-le-myelome-multiple http://www.mypharma-editions.com/deux-nouveaux-guides-ald-patients-sur-la-leucemie-lymphoide-chronique-et-le-myelome-multiple#comments Mon, 12 Dec 2011 13:28:21 +0000 morgdave http://www.mypharma-editions.com/?p=22689 http://www.mypharma-editions.com/deux-nouveaux-guides-ald-patients-sur-la-leucemie-lymphoide-chronique-et-le-myelome-multiple/feed 0 http://www.mypharma-editions.com/celgene-une-etude-de-phase-i-sur-lazacitidine-orale-dans-la-leucemie-myeloide-aigue-presentee-a-l%e2%80%99ash http://www.mypharma-editions.com/celgene-une-etude-de-phase-i-sur-lazacitidine-orale-dans-la-leucemie-myeloide-aigue-presentee-a-l%e2%80%99ash#comments Mon, 12 Dec 2011 08:28:21 +0000 morgdave http://www.mypharma-editions.com/?p=22669 http://www.mypharma-editions.com/celgene-une-etude-de-phase-i-sur-lazacitidine-orale-dans-la-leucemie-myeloide-aigue-presentee-a-l%e2%80%99ash/feed 0 http://www.mypharma-editions.com/janssen-nouvelles-donnees-sur-lefficacite-de-velcade-presentees-au-congres-de-l%e2%80%99ash http://www.mypharma-editions.com/janssen-nouvelles-donnees-sur-lefficacite-de-velcade-presentees-au-congres-de-l%e2%80%99ash#comments Mon, 12 Dec 2011 08:22:44 +0000 morgdave http://www.mypharma-editions.com/?p=22667 http://www.mypharma-editions.com/janssen-nouvelles-donnees-sur-lefficacite-de-velcade-presentees-au-congres-de-l%e2%80%99ash/feed 0 http://www.mypharma-editions.com/cancer-du-sein-resultats-positifs-d%e2%80%99une-etude-pivot-de-phase-iii-sur-le-pertuzumab-de-roche http://www.mypharma-editions.com/cancer-du-sein-resultats-positifs-d%e2%80%99une-etude-pivot-de-phase-iii-sur-le-pertuzumab-de-roche#comments Thu, 08 Dec 2011 07:59:52 +0000 morgdave http://www.mypharma-editions.com/?p=22626 http://www.mypharma-editions.com/cancer-du-sein-resultats-positifs-d%e2%80%99une-etude-pivot-de-phase-iii-sur-le-pertuzumab-de-roche/feed 0 http://www.mypharma-editions.com/unicancer-christian-cailliot-nomme-directeur-de-la-recherche http://www.mypharma-editions.com/unicancer-christian-cailliot-nomme-directeur-de-la-recherche#comments Tue, 06 Dec 2011 16:13:51 +0000 morgdave http://www.mypharma-editions.com/?p=22608 http://www.mypharma-editions.com/unicancer-christian-cailliot-nomme-directeur-de-la-recherche/feed 0 http://www.mypharma-editions.com/sabcs-2011-roche-presentera-de-nouvelles-donnees-sur-le-traitement-du-cancer-du-sein-her2-positif-au-san-antonio-breast-cancer-symposium-2011 http://www.mypharma-editions.com/sabcs-2011-roche-presentera-de-nouvelles-donnees-sur-le-traitement-du-cancer-du-sein-her2-positif-au-san-antonio-breast-cancer-symposium-2011#comments Wed, 30 Nov 2011 08:41:07 +0000 morgdave http://www.mypharma-editions.com/?p=22512 http://www.mypharma-editions.com/sabcs-2011-roche-presentera-de-nouvelles-donnees-sur-le-traitement-du-cancer-du-sein-her2-positif-au-san-antonio-breast-cancer-symposium-2011/feed 1 http://www.mypharma-editions.com/nanobiotix-obtient-un-nouveau-financement-dun-million-deuros-doseo http://www.mypharma-editions.com/nanobiotix-obtient-un-nouveau-financement-dun-million-deuros-doseo#comments Wed, 23 Nov 2011 16:52:55 +0000 morgdave http://www.mypharma-editions.com/?p=22457 http://www.mypharma-editions.com/nanobiotix-obtient-un-nouveau-financement-dun-million-deuros-doseo/feed 0 http://www.mypharma-editions.com/cancers-de-l%e2%80%99ovaire-une-double-signature-predictive-de-l%e2%80%99agressivite-tumorale-et-de-la-reponse-au-traitement http://www.mypharma-editions.com/cancers-de-l%e2%80%99ovaire-une-double-signature-predictive-de-l%e2%80%99agressivite-tumorale-et-de-la-reponse-au-traitement#comments Wed, 23 Nov 2011 09:28:29 +0000 morgdave http://www.mypharma-editions.com/?p=22443 http://www.mypharma-editions.com/cancers-de-l%e2%80%99ovaire-une-double-signature-predictive-de-l%e2%80%99agressivite-tumorale-et-de-la-reponse-au-traitement/feed 0 http://www.mypharma-editions.com/cancers-de-la-peau-l%e2%80%99inca-publie-une-fiche-repere-sur-la-detection-precoce http://www.mypharma-editions.com/cancers-de-la-peau-l%e2%80%99inca-publie-une-fiche-repere-sur-la-detection-precoce#comments Tue, 22 Nov 2011 09:26:44 +0000 morgdave http://www.mypharma-editions.com/?p=22421 http://www.mypharma-editions.com/cancers-de-la-peau-l%e2%80%99inca-publie-une-fiche-repere-sur-la-detection-precoce/feed 0 http://www.mypharma-editions.com/cancer-de-la-peau-la-fda-accepte-le-depot-du-dossier-d%e2%80%99enregistrement-du-vismodegib-de-roche http://www.mypharma-editions.com/cancer-de-la-peau-la-fda-accepte-le-depot-du-dossier-d%e2%80%99enregistrement-du-vismodegib-de-roche#comments Fri, 11 Nov 2011 10:05:56 +0000 morgdave http://www.mypharma-editions.com/?p=22216 http://www.mypharma-editions.com/cancer-de-la-peau-la-fda-accepte-le-depot-du-dossier-d%e2%80%99enregistrement-du-vismodegib-de-roche/feed 0 http://www.mypharma-editions.com/transgene-et-jennerex-donnees-positives-d%e2%80%99une-etude-de-phase-ii-de-jx594tg6006-dans-le-cancer-du-foie-avance http://www.mypharma-editions.com/transgene-et-jennerex-donnees-positives-d%e2%80%99une-etude-de-phase-ii-de-jx594tg6006-dans-le-cancer-du-foie-avance#comments Tue, 08 Nov 2011 08:25:43 +0000 morgdave http://www.mypharma-editions.com/?p=22148 http://www.mypharma-editions.com/transgene-et-jennerex-donnees-positives-d%e2%80%99une-etude-de-phase-ii-de-jx594tg6006-dans-le-cancer-du-foie-avance/feed 0 http://www.mypharma-editions.com/cancer-l%e2%80%99inca-met-en-ligne-une-base-de-donnees-des-projets-de-recherche http://www.mypharma-editions.com/cancer-l%e2%80%99inca-met-en-ligne-une-base-de-donnees-des-projets-de-recherche#comments Sat, 05 Nov 2011 09:03:11 +0000 morgdave http://www.mypharma-editions.com/?p=22110 http://www.mypharma-editions.com/cancer-l%e2%80%99inca-met-en-ligne-une-base-de-donnees-des-projets-de-recherche/feed 1 http://www.mypharma-editions.com/cancer-du-foie-transgene-et-jennerex-annoncent-l%e2%80%99inclusion-du-premier-patient-dans-un-essai-clinique-de-phase-iib-sur-jx594tg6006 http://www.mypharma-editions.com/cancer-du-foie-transgene-et-jennerex-annoncent-l%e2%80%99inclusion-du-premier-patient-dans-un-essai-clinique-de-phase-iib-sur-jx594tg6006#comments Fri, 04 Nov 2011 12:06:45 +0000 morgdave http://www.mypharma-editions.com/?p=22086 http://www.mypharma-editions.com/cancer-du-foie-transgene-et-jennerex-annoncent-l%e2%80%99inclusion-du-premier-patient-dans-un-essai-clinique-de-phase-iib-sur-jx594tg6006/feed 0 http://www.mypharma-editions.com/cancers-gynecologiques-lancement-d%e2%80%99un-programme-d%e2%80%99actions-integrees-de-recherche-pair http://www.mypharma-editions.com/cancers-gynecologiques-lancement-d%e2%80%99un-programme-d%e2%80%99actions-integrees-de-recherche-pair#comments Tue, 01 Nov 2011 10:27:40 +0000 morgdave http://www.mypharma-editions.com/?p=22004 http://www.mypharma-editions.com/cancers-gynecologiques-lancement-d%e2%80%99un-programme-d%e2%80%99actions-integrees-de-recherche-pair/feed 0 http://www.mypharma-editions.com/%c2%ab-radon-et-cancer-%c2%bb-l%e2%80%99inca-publie-une-fiche-repere http://www.mypharma-editions.com/%c2%ab-radon-et-cancer-%c2%bb-l%e2%80%99inca-publie-une-fiche-repere#comments Sat, 29 Oct 2011 08:21:13 +0000 morgdave http://www.mypharma-editions.com/?p=21977 http://www.mypharma-editions.com/%c2%ab-radon-et-cancer-%c2%bb-l%e2%80%99inca-publie-une-fiche-repere/feed 0 http://www.mypharma-editions.com/taconic-et-oncodesign-vont-developper-des-outils-de-recherche-en-oncologie http://www.mypharma-editions.com/taconic-et-oncodesign-vont-developper-des-outils-de-recherche-en-oncologie#comments Tue, 25 Oct 2011 09:38:42 +0000 morgdave http://www.mypharma-editions.com/?p=21893 http://www.mypharma-editions.com/taconic-et-oncodesign-vont-developper-des-outils-de-recherche-en-oncologie/feed 0 http://www.mypharma-editions.com/cancer-de-l%e2%80%99estomac-et-de-l%e2%80%99oesophage-deux-nouveaux-guides-ald-pour-les-medecins-traitants http://www.mypharma-editions.com/cancer-de-l%e2%80%99estomac-et-de-l%e2%80%99oesophage-deux-nouveaux-guides-ald-pour-les-medecins-traitants#comments Tue, 25 Oct 2011 07:53:10 +0000 morgdave http://www.mypharma-editions.com/?p=21877 http://www.mypharma-editions.com/cancer-de-l%e2%80%99estomac-et-de-l%e2%80%99oesophage-deux-nouveaux-guides-ald-pour-les-medecins-traitants/feed 0 http://www.mypharma-editions.com/un-gene-de-predisposition-commun-au-melanome-et-au-cancer-du-rein http://www.mypharma-editions.com/un-gene-de-predisposition-commun-au-melanome-et-au-cancer-du-rein#comments Fri, 21 Oct 2011 13:58:39 +0000 morgdave http://www.mypharma-editions.com/?p=21839 http://www.mypharma-editions.com/un-gene-de-predisposition-commun-au-melanome-et-au-cancer-du-rein/feed 0 http://www.mypharma-editions.com/myelome-multiple-ab-science-recrute-le-1er-patient-de-l%e2%80%99etude-de-phase-3-du-masitinib http://www.mypharma-editions.com/myelome-multiple-ab-science-recrute-le-1er-patient-de-l%e2%80%99etude-de-phase-3-du-masitinib#comments Mon, 17 Oct 2011 16:37:34 +0000 morgdave http://www.mypharma-editions.com/?p=21749 http://www.mypharma-editions.com/myelome-multiple-ab-science-recrute-le-1er-patient-de-l%e2%80%99etude-de-phase-3-du-masitinib/feed 0 http://www.mypharma-editions.com/msd-france-propose-une-application-iphone-pour-les-patients-sous-chimiotherapie http://www.mypharma-editions.com/msd-france-propose-une-application-iphone-pour-les-patients-sous-chimiotherapie#comments Fri, 14 Oct 2011 13:21:48 +0000 morgdave http://www.mypharma-editions.com/?p=21708 http://www.mypharma-editions.com/msd-france-propose-une-application-iphone-pour-les-patients-sous-chimiotherapie/feed 0 http://www.mypharma-editions.com/deux-guides-ald-patients-sur-les-cancers-du-testicule-et-de-l%e2%80%99endometre http://www.mypharma-editions.com/deux-guides-ald-patients-sur-les-cancers-du-testicule-et-de-l%e2%80%99endometre#comments Thu, 13 Oct 2011 11:53:23 +0000 morgdave http://www.mypharma-editions.com/?p=21672 http://www.mypharma-editions.com/deux-guides-ald-patients-sur-les-cancers-du-testicule-et-de-l%e2%80%99endometre/feed 0 http://www.mypharma-editions.com/depistage-des-cancers-et-medecins-generalistes-resultats-de-l%e2%80%99enquete-barometrique-incabva http://www.mypharma-editions.com/depistage-des-cancers-et-medecins-generalistes-resultats-de-l%e2%80%99enquete-barometrique-incabva#comments Wed, 12 Oct 2011 08:03:54 +0000 morgdave http://www.mypharma-editions.com/?p=21615 http://www.mypharma-editions.com/depistage-des-cancers-et-medecins-generalistes-resultats-de-l%e2%80%99enquete-barometrique-incabva/feed 0 http://www.mypharma-editions.com/le-cancerologue-victor-izrael-candidat-aux-presidentielles-de-2012 http://www.mypharma-editions.com/le-cancerologue-victor-izrael-candidat-aux-presidentielles-de-2012#comments Wed, 05 Oct 2011 08:48:07 +0000 morgdave http://www.mypharma-editions.com/?p=21481 http://www.mypharma-editions.com/le-cancerologue-victor-izrael-candidat-aux-presidentielles-de-2012/feed 0 http://www.mypharma-editions.com/un-guide-cancer-info-sur-la-polypose-adenomateuse-familiale http://www.mypharma-editions.com/un-guide-cancer-info-sur-la-polypose-adenomateuse-familiale#comments Thu, 29 Sep 2011 12:06:34 +0000 morgdave http://www.mypharma-editions.com/?p=21357 http://www.mypharma-editions.com/un-guide-cancer-info-sur-la-polypose-adenomateuse-familiale/feed 0 http://www.mypharma-editions.com/nora-berra-lance-l%e2%80%99edition-2011-d%e2%80%99octobre-rose http://www.mypharma-editions.com/nora-berra-lance-l%e2%80%99edition-2011-d%e2%80%99octobre-rose#comments Wed, 28 Sep 2011 13:54:07 +0000 morgdave http://www.mypharma-editions.com/?p=21326 http://www.mypharma-editions.com/nora-berra-lance-l%e2%80%99edition-2011-d%e2%80%99octobre-rose/feed 0 http://www.mypharma-editions.com/cancer-l%e2%80%99afssaps-informe-sur-une-rupture-de-stock-imminente-de-caelyx http://www.mypharma-editions.com/cancer-l%e2%80%99afssaps-informe-sur-une-rupture-de-stock-imminente-de-caelyx#comments Tue, 27 Sep 2011 13:24:15 +0000 morgdave http://www.mypharma-editions.com/?p=21289 http://www.mypharma-editions.com/cancer-l%e2%80%99afssaps-informe-sur-une-rupture-de-stock-imminente-de-caelyx/feed 0 http://www.mypharma-editions.com/cancer-du-sein-metastatique-resultats-positifs-pour-le-t-dm1-un-medicament-experimental-de-roche http://www.mypharma-editions.com/cancer-du-sein-metastatique-resultats-positifs-pour-le-t-dm1-un-medicament-experimental-de-roche#comments Mon, 26 Sep 2011 07:36:36 +0000 morgdave http://www.mypharma-editions.com/?p=21240 http://www.mypharma-editions.com/cancer-du-sein-metastatique-resultats-positifs-pour-le-t-dm1-un-medicament-experimental-de-roche/feed 1 http://www.mypharma-editions.com/roche-avis-positif-des-autorites-europeennes-pour-avastin-contre-le-cancer-de-l%e2%80%99ovaire-avance http://www.mypharma-editions.com/roche-avis-positif-des-autorites-europeennes-pour-avastin-contre-le-cancer-de-l%e2%80%99ovaire-avance#comments Fri, 23 Sep 2011 12:53:25 +0000 morgdave http://www.mypharma-editions.com/?p=21203 http://www.mypharma-editions.com/roche-avis-positif-des-autorites-europeennes-pour-avastin-contre-le-cancer-de-l%e2%80%99ovaire-avance/feed 0 http://www.mypharma-editions.com/cancer-roche-va-presenter-des-resultats-encourageants-sur-ses-traitements-experimentaux http://www.mypharma-editions.com/cancer-roche-va-presenter-des-resultats-encourageants-sur-ses-traitements-experimentaux#comments Mon, 19 Sep 2011 06:34:52 +0000 morgdave http://www.mypharma-editions.com/?p=21051 http://www.mypharma-editions.com/cancer-roche-va-presenter-des-resultats-encourageants-sur-ses-traitements-experimentaux/feed 0 http://www.mypharma-editions.com/sanofi-l%e2%80%99exclusivite-d%e2%80%99eloxatine%c2%ae-sur-le-marche-americain-maintenue-jusqu%e2%80%99en-aout-2012 http://www.mypharma-editions.com/sanofi-l%e2%80%99exclusivite-d%e2%80%99eloxatine%c2%ae-sur-le-marche-americain-maintenue-jusqu%e2%80%99en-aout-2012#comments Mon, 19 Sep 2011 05:59:12 +0000 morgdave http://www.mypharma-editions.com/?p=21049 http://www.mypharma-editions.com/sanofi-l%e2%80%99exclusivite-d%e2%80%99eloxatine%c2%ae-sur-le-marche-americain-maintenue-jusqu%e2%80%99en-aout-2012/feed 0 http://www.mypharma-editions.com/cancers-la-sante-est-dans-le-pre http://www.mypharma-editions.com/cancers-la-sante-est-dans-le-pre#comments Sat, 17 Sep 2011 07:53:52 +0000 morgdave http://www.mypharma-editions.com/?p=21024 http://www.mypharma-editions.com/cancers-la-sante-est-dans-le-pre/feed 0 http://www.mypharma-editions.com/lutte-contre-le-cancer-ge-healthcare-va-investir-un-milliard-de-dollars http://www.mypharma-editions.com/lutte-contre-le-cancer-ge-healthcare-va-investir-un-milliard-de-dollars#comments Fri, 16 Sep 2011 08:13:25 +0000 morgdave http://www.mypharma-editions.com/?p=21004 http://www.mypharma-editions.com/lutte-contre-le-cancer-ge-healthcare-va-investir-un-milliard-de-dollars/feed 0 http://www.mypharma-editions.com/la-journee-nationale-de-la-prostate-se-deroulera-le-15-septembre-2011 http://www.mypharma-editions.com/la-journee-nationale-de-la-prostate-se-deroulera-le-15-septembre-2011#comments Wed, 14 Sep 2011 09:33:10 +0000 morgdave http://www.mypharma-editions.com/?p=20966 http://www.mypharma-editions.com/la-journee-nationale-de-la-prostate-se-deroulera-le-15-septembre-2011/feed 0 http://www.mypharma-editions.com/bioalliance-pharma-resultats-positifs-pour-sa-biotherapie-amep%c2%ae-dans-le-melanome-metastatique http://www.mypharma-editions.com/bioalliance-pharma-resultats-positifs-pour-sa-biotherapie-amep%c2%ae-dans-le-melanome-metastatique#comments Wed, 14 Sep 2011 07:59:24 +0000 morgdave http://www.mypharma-editions.com/?p=20955 http://www.mypharma-editions.com/bioalliance-pharma-resultats-positifs-pour-sa-biotherapie-amep%c2%ae-dans-le-melanome-metastatique/feed 0 http://www.mypharma-editions.com/cancer-nanobiotix-demarre-un-essai-clinique-avec-son-produit-nbtxr3 http://www.mypharma-editions.com/cancer-nanobiotix-demarre-un-essai-clinique-avec-son-produit-nbtxr3#comments Tue, 13 Sep 2011 12:44:25 +0000 morgdave http://www.mypharma-editions.com/?p=20937 http://www.mypharma-editions.com/cancer-nanobiotix-demarre-un-essai-clinique-avec-son-produit-nbtxr3/feed 0 http://www.mypharma-editions.com/cancers-du-sein-un-nouveau-marqueur-du-risque-de-metastases-pulmonaires http://www.mypharma-editions.com/cancers-du-sein-un-nouveau-marqueur-du-risque-de-metastases-pulmonaires#comments Sat, 10 Sep 2011 15:23:38 +0000 morgdave http://www.mypharma-editions.com/?p=20883 http://www.mypharma-editions.com/cancers-du-sein-un-nouveau-marqueur-du-risque-de-metastases-pulmonaires/feed 0 http://www.mypharma-editions.com/feu-vert-de-l%e2%80%99ue-pour-zytiga%c2%ae-dans-le-cancer-metastatique-de-la-prostate-resistant-a-la-castration http://www.mypharma-editions.com/feu-vert-de-l%e2%80%99ue-pour-zytiga%c2%ae-dans-le-cancer-metastatique-de-la-prostate-resistant-a-la-castration#comments Thu, 08 Sep 2011 07:22:31 +0000 morgdave http://www.mypharma-editions.com/?p=20840 http://www.mypharma-editions.com/feu-vert-de-l%e2%80%99ue-pour-zytiga%c2%ae-dans-le-cancer-metastatique-de-la-prostate-resistant-a-la-castration/feed 0 http://www.mypharma-editions.com/le-pr-pierre-teillac-nomme-directeur-de-l%e2%80%99ensemble-hospitalier-de-l%e2%80%99institut-curie http://www.mypharma-editions.com/le-pr-pierre-teillac-nomme-directeur-de-l%e2%80%99ensemble-hospitalier-de-l%e2%80%99institut-curie#comments Wed, 07 Sep 2011 12:53:06 +0000 morgdave http://www.mypharma-editions.com/?p=20816 http://www.mypharma-editions.com/le-pr-pierre-teillac-nomme-directeur-de-l%e2%80%99ensemble-hospitalier-de-l%e2%80%99institut-curie/feed 0 http://www.mypharma-editions.com/france-lymphome-espoir-publie-un-guide-sur-le-lymphome-non-hodgkinien http://www.mypharma-editions.com/france-lymphome-espoir-publie-un-guide-sur-le-lymphome-non-hodgkinien#comments Wed, 07 Sep 2011 08:44:55 +0000 morgdave http://www.mypharma-editions.com/?p=20811 http://www.mypharma-editions.com/france-lymphome-espoir-publie-un-guide-sur-le-lymphome-non-hodgkinien/feed 0 http://www.mypharma-editions.com/cancer-du-foie-les-resultats-de-survie-de-livatag%c2%ae-presentes-au-congres-de-l%e2%80%99ilca http://www.mypharma-editions.com/cancer-du-foie-les-resultats-de-survie-de-livatag%c2%ae-presentes-au-congres-de-l%e2%80%99ilca#comments Wed, 07 Sep 2011 08:32:18 +0000 morgdave http://www.mypharma-editions.com/?p=20808 http://www.mypharma-editions.com/cancer-du-foie-les-resultats-de-survie-de-livatag%c2%ae-presentes-au-congres-de-l%e2%80%99ilca/feed 0 http://www.mypharma-editions.com/novartis-feu-vert-de-l%e2%80%99ue-pour-afinitor%c2%ae-dans-le-cancer-du-pancreas http://www.mypharma-editions.com/novartis-feu-vert-de-l%e2%80%99ue-pour-afinitor%c2%ae-dans-le-cancer-du-pancreas#comments Mon, 05 Sep 2011 08:51:56 +0000 morgdave http://www.mypharma-editions.com/?p=20750 http://www.mypharma-editions.com/novartis-feu-vert-de-l%e2%80%99ue-pour-afinitor%c2%ae-dans-le-cancer-du-pancreas/feed 1 http://www.mypharma-editions.com/la-journee-mondiale-du-lymphome-se-deroule-le-15-septembre-2011 http://www.mypharma-editions.com/la-journee-mondiale-du-lymphome-se-deroule-le-15-septembre-2011#comments Thu, 01 Sep 2011 12:51:46 +0000 morgdave http://www.mypharma-editions.com/?p=20726 http://www.mypharma-editions.com/la-journee-mondiale-du-lymphome-se-deroule-le-15-septembre-2011/feed 0 http://www.mypharma-editions.com/merck-millipore-robert-yates-nomme-president-a-partir-du-1er-septembre http://www.mypharma-editions.com/merck-millipore-robert-yates-nomme-president-a-partir-du-1er-septembre#comments Wed, 31 Aug 2011 07:42:10 +0000 morgdave http://www.mypharma-editions.com/?p=20706 http://www.mypharma-editions.com/merck-millipore-robert-yates-nomme-president-a-partir-du-1er-septembre/feed 0 http://www.mypharma-editions.com/resultats-encourageants-pour-un-protocole-d%e2%80%99immunotherapie-dans-la-leucemie-lymphoide-chronique-avancee http://www.mypharma-editions.com/resultats-encourageants-pour-un-protocole-d%e2%80%99immunotherapie-dans-la-leucemie-lymphoide-chronique-avancee#comments Thu, 18 Aug 2011 08:15:58 +0000 morgdave http://www.mypharma-editions.com/?p=20595 http://www.mypharma-editions.com/resultats-encourageants-pour-un-protocole-d%e2%80%99immunotherapie-dans-la-leucemie-lymphoide-chronique-avancee/feed 0 http://www.mypharma-editions.com/roche-feu-vert-de-la-fda-pour-zelboraf-et-son-test-compagnon-dans-le-melanome-metastatique-a-gene-braf-mute http://www.mypharma-editions.com/roche-feu-vert-de-la-fda-pour-zelboraf-et-son-test-compagnon-dans-le-melanome-metastatique-a-gene-braf-mute#comments Thu, 18 Aug 2011 08:10:22 +0000 morgdave http://www.mypharma-editions.com/?p=20593 http://www.mypharma-editions.com/roche-feu-vert-de-la-fda-pour-zelboraf-et-son-test-compagnon-dans-le-melanome-metastatique-a-gene-braf-mute/feed 0 http://www.mypharma-editions.com/des-vaisseaux-sanguins-participent-a-leradication-des-tumeurs http://www.mypharma-editions.com/des-vaisseaux-sanguins-participent-a-leradication-des-tumeurs#comments Wed, 17 Aug 2011 09:10:51 +0000 morgdave http://www.mypharma-editions.com/?p=20574 http://www.mypharma-editions.com/des-vaisseaux-sanguins-participent-a-leradication-des-tumeurs/feed 0 http://www.mypharma-editions.com/31-nouveaux-projets-de-recherche-biomedicale-finances-par-l%e2%80%99inca http://www.mypharma-editions.com/31-nouveaux-projets-de-recherche-biomedicale-finances-par-l%e2%80%99inca#comments Thu, 28 Jul 2011 07:46:40 +0000 morgdave http://www.mypharma-editions.com/?p=20445 http://www.mypharma-editions.com/31-nouveaux-projets-de-recherche-biomedicale-finances-par-l%e2%80%99inca/feed 0 http://www.mypharma-editions.com/troisieme-rapport-davancement-du-plan-cancer-2009-2013 http://www.mypharma-editions.com/troisieme-rapport-davancement-du-plan-cancer-2009-2013#comments Tue, 26 Jul 2011 08:13:32 +0000 morgdave http://www.mypharma-editions.com/?p=20422 http://www.mypharma-editions.com/troisieme-rapport-davancement-du-plan-cancer-2009-2013/feed 0 http://www.mypharma-editions.com/avis-favorable-du-chmp-pour-zytiga%c2%ae-de-janssen-cilag-dans-le-cancer-de-la-prostate http://www.mypharma-editions.com/avis-favorable-du-chmp-pour-zytiga%c2%ae-de-janssen-cilag-dans-le-cancer-de-la-prostate#comments Mon, 25 Jul 2011 13:59:37 +0000 morgdave http://www.mypharma-editions.com/?p=20417 http://www.mypharma-editions.com/avis-favorable-du-chmp-pour-zytiga%c2%ae-de-janssen-cilag-dans-le-cancer-de-la-prostate/feed 0 http://www.mypharma-editions.com/roche-avis-positif-du-chmp-pour-tarceva-dans-une-forme-genetiquement-distincte-de-cancer-du-poumon http://www.mypharma-editions.com/roche-avis-positif-du-chmp-pour-tarceva-dans-une-forme-genetiquement-distincte-de-cancer-du-poumon#comments Mon, 25 Jul 2011 07:48:49 +0000 morgdave http://www.mypharma-editions.com/?p=20401 http://www.mypharma-editions.com/roche-avis-positif-du-chmp-pour-tarceva-dans-une-forme-genetiquement-distincte-de-cancer-du-poumon/feed 0 http://www.mypharma-editions.com/exonhit-annonce-le-succes-de-la-seconde-phase-de-validation-clinique-d%e2%80%99eht-dx14 http://www.mypharma-editions.com/exonhit-annonce-le-succes-de-la-seconde-phase-de-validation-clinique-d%e2%80%99eht-dx14#comments Wed, 20 Jul 2011 12:19:30 +0000 morgdave http://www.mypharma-editions.com/?p=20366 http://www.mypharma-editions.com/exonhit-annonce-le-succes-de-la-seconde-phase-de-validation-clinique-d%e2%80%99eht-dx14/feed 0 http://www.mypharma-editions.com/methotrexate-par-voie-orale-des-deces-lies-a-des-erreurs-de-prescription-ou-d%e2%80%99administration http://www.mypharma-editions.com/methotrexate-par-voie-orale-des-deces-lies-a-des-erreurs-de-prescription-ou-d%e2%80%99administration#comments Wed, 13 Jul 2011 10:21:57 +0000 morgdave http://www.mypharma-editions.com/?p=20284 http://www.mypharma-editions.com/methotrexate-par-voie-orale-des-deces-lies-a-des-erreurs-de-prescription-ou-d%e2%80%99administration/feed 0 http://www.mypharma-editions.com/l%e2%80%99inecalcitol-d%e2%80%99hybrigenics-inhibe-la-croissance-in-vitro-et-in-vivo-de-cellules-de-cancer-de-la-prostate-hormono-dependant http://www.mypharma-editions.com/l%e2%80%99inecalcitol-d%e2%80%99hybrigenics-inhibe-la-croissance-in-vitro-et-in-vivo-de-cellules-de-cancer-de-la-prostate-hormono-dependant#comments Wed, 13 Jul 2011 09:33:08 +0000 morgdave http://www.mypharma-editions.com/?p=20273 http://www.mypharma-editions.com/l%e2%80%99inecalcitol-d%e2%80%99hybrigenics-inhibe-la-croissance-in-vitro-et-in-vivo-de-cellules-de-cancer-de-la-prostate-hormono-dependant/feed 0 http://www.mypharma-editions.com/cancerologie-partenariat-entre-ipsen-et-l%e2%80%99institut-gustave-roussy http://www.mypharma-editions.com/cancerologie-partenariat-entre-ipsen-et-l%e2%80%99institut-gustave-roussy#comments Tue, 12 Jul 2011 13:03:06 +0000 morgdave http://www.mypharma-editions.com/?p=20256 http://www.mypharma-editions.com/cancerologie-partenariat-entre-ipsen-et-l%e2%80%99institut-gustave-roussy/feed 0 http://www.mypharma-editions.com/les-chiffres-2011-du-cancer-en-france http://www.mypharma-editions.com/les-chiffres-2011-du-cancer-en-france#comments Mon, 11 Jul 2011 14:13:06 +0000 morgdave http://www.mypharma-editions.com/?p=20227 http://www.mypharma-editions.com/les-chiffres-2011-du-cancer-en-france/feed 0 http://www.mypharma-editions.com/identification-d%e2%80%99un-nouveau-gene-suppresseur-de-tumeur http://www.mypharma-editions.com/identification-d%e2%80%99un-nouveau-gene-suppresseur-de-tumeur#comments Thu, 07 Jul 2011 08:53:12 +0000 morgdave http://www.mypharma-editions.com/?p=20140 http://www.mypharma-editions.com/identification-d%e2%80%99un-nouveau-gene-suppresseur-de-tumeur/feed 0 http://www.mypharma-editions.com/feu-vert-de-l%e2%80%99ue-a-avastin-de-roche-pour-une-extension-de-son-champ-d%e2%80%99application-lors-de-cancer-du-sein-metastatique http://www.mypharma-editions.com/feu-vert-de-l%e2%80%99ue-a-avastin-de-roche-pour-une-extension-de-son-champ-d%e2%80%99application-lors-de-cancer-du-sein-metastatique#comments Thu, 30 Jun 2011 08:08:47 +0000 morgdave http://www.mypharma-editions.com/?p=20086 http://www.mypharma-editions.com/feu-vert-de-l%e2%80%99ue-a-avastin-de-roche-pour-une-extension-de-son-champ-d%e2%80%99application-lors-de-cancer-du-sein-metastatique/feed 0 http://www.mypharma-editions.com/bioalliance-pharma-soumet-un-essai-clinique-de-phase-iii-pour-livatag%c2%ae-a-l%e2%80%99afssaps http://www.mypharma-editions.com/bioalliance-pharma-soumet-un-essai-clinique-de-phase-iii-pour-livatag%c2%ae-a-l%e2%80%99afssaps#comments Tue, 28 Jun 2011 07:07:22 +0000 morgdave http://www.mypharma-editions.com/?p=20028 http://www.mypharma-editions.com/bioalliance-pharma-soumet-un-essai-clinique-de-phase-iii-pour-livatag%c2%ae-a-l%e2%80%99afssaps/feed 0 http://www.mypharma-editions.com/le-pr-jean-pierre-grunfeld-rejoint-le-conseil-d%e2%80%99administration-de-l%e2%80%99arc http://www.mypharma-editions.com/le-pr-jean-pierre-grunfeld-rejoint-le-conseil-d%e2%80%99administration-de-l%e2%80%99arc#comments Mon, 27 Jun 2011 18:50:28 +0000 morgdave http://www.mypharma-editions.com/?p=20016 http://www.mypharma-editions.com/le-pr-jean-pierre-grunfeld-rejoint-le-conseil-d%e2%80%99administration-de-l%e2%80%99arc/feed 0 http://www.mypharma-editions.com/cancer-du-pancreas-erytech-pharma-termine-le-recrutement-des-patients-dans-son-essai-clinique-de-phase-i http://www.mypharma-editions.com/cancer-du-pancreas-erytech-pharma-termine-le-recrutement-des-patients-dans-son-essai-clinique-de-phase-i#comments Mon, 27 Jun 2011 12:16:39 +0000 morgdave http://www.mypharma-editions.com/?p=20007 http://www.mypharma-editions.com/cancer-du-pancreas-erytech-pharma-termine-le-recrutement-des-patients-dans-son-essai-clinique-de-phase-i/feed 0 http://www.mypharma-editions.com/linca-soutient-la-3eme-edition-du-symposium-win http://www.mypharma-editions.com/linca-soutient-la-3eme-edition-du-symposium-win#comments Fri, 24 Jun 2011 11:10:17 +0000 morgdave http://www.mypharma-editions.com/?p=19961 http://www.mypharma-editions.com/linca-soutient-la-3eme-edition-du-symposium-win/feed 0 http://www.mypharma-editions.com/oncologie-roche-et-evotec-vont-developper-de-nouveaux-biomarqueurs http://www.mypharma-editions.com/oncologie-roche-et-evotec-vont-developper-de-nouveaux-biomarqueurs#comments Fri, 24 Jun 2011 06:29:38 +0000 morgdave http://www.mypharma-editions.com/?p=19935 http://www.mypharma-editions.com/oncologie-roche-et-evotec-vont-developper-de-nouveaux-biomarqueurs/feed 0 http://www.mypharma-editions.com/cecile-courreges-nommee-directrice-generale-de-l%e2%80%99institut-national-du-cancer http://www.mypharma-editions.com/cecile-courreges-nommee-directrice-generale-de-l%e2%80%99institut-national-du-cancer#comments Tue, 21 Jun 2011 09:10:38 +0000 morgdave http://www.mypharma-editions.com/?p=19865 http://www.mypharma-editions.com/cecile-courreges-nommee-directrice-generale-de-l%e2%80%99institut-national-du-cancer/feed 0 http://www.mypharma-editions.com/l%e2%80%99inca-labellise-les-deux-premiers-sites-de-recherche-integree-sur-le-cancer-siric http://www.mypharma-editions.com/l%e2%80%99inca-labellise-les-deux-premiers-sites-de-recherche-integree-sur-le-cancer-siric#comments Mon, 20 Jun 2011 09:18:34 +0000 morgdave http://www.mypharma-editions.com/?p=19841 http://www.mypharma-editions.com/l%e2%80%99inca-labellise-les-deux-premiers-sites-de-recherche-integree-sur-le-cancer-siric/feed 0 http://www.mypharma-editions.com/roche-resultats-positifs-pour-le-vismodegib-dans-une-forme-rare-de-cancer-de-la-peau http://www.mypharma-editions.com/roche-resultats-positifs-pour-le-vismodegib-dans-une-forme-rare-de-cancer-de-la-peau#comments Mon, 20 Jun 2011 06:42:00 +0000 morgdave http://www.mypharma-editions.com/?p=19834 http://www.mypharma-editions.com/roche-resultats-positifs-pour-le-vismodegib-dans-une-forme-rare-de-cancer-de-la-peau/feed 0 http://www.mypharma-editions.com/cancer-du-col-de-l%e2%80%99uterus-l%e2%80%99inca-publie-un-guide-patients-sur-les-traitements http://www.mypharma-editions.com/cancer-du-col-de-l%e2%80%99uterus-l%e2%80%99inca-publie-un-guide-patients-sur-les-traitements#comments Sat, 18 Jun 2011 08:10:25 +0000 morgdave http://www.mypharma-editions.com/?p=19822 http://www.mypharma-editions.com/cancer-du-col-de-l%e2%80%99uterus-l%e2%80%99inca-publie-un-guide-patients-sur-les-traitements/feed 0 http://www.mypharma-editions.com/cancer-le-3eme-symposium-win-se-tiendra-a-paris-du-6-au-8-juillet-2011 http://www.mypharma-editions.com/cancer-le-3eme-symposium-win-se-tiendra-a-paris-du-6-au-8-juillet-2011#comments Thu, 16 Jun 2011 15:46:12 +0000 morgdave http://www.mypharma-editions.com/?p=19783 http://www.mypharma-editions.com/cancer-le-3eme-symposium-win-se-tiendra-a-paris-du-6-au-8-juillet-2011/feed 0 http://www.mypharma-editions.com/la-has-et-l%e2%80%99inca-publient-un-nouveau-guide-ald-pour-les-medecins-traitants http://www.mypharma-editions.com/la-has-et-l%e2%80%99inca-publient-un-nouveau-guide-ald-pour-les-medecins-traitants#comments Tue, 14 Jun 2011 09:07:45 +0000 morgdave http://www.mypharma-editions.com/?p=19738 http://www.mypharma-editions.com/la-has-et-l%e2%80%99inca-publient-un-nouveau-guide-ald-pour-les-medecins-traitants/feed 0 http://www.mypharma-editions.com/cancerologie-78-projets-de-recherche-clinique-et-translationnelle-soutenus-par-l%e2%80%99inca-et-la-dgos http://www.mypharma-editions.com/cancerologie-78-projets-de-recherche-clinique-et-translationnelle-soutenus-par-l%e2%80%99inca-et-la-dgos#comments Wed, 08 Jun 2011 07:51:45 +0000 morgdave http://www.mypharma-editions.com/?p=19658 http://www.mypharma-editions.com/cancerologie-78-projets-de-recherche-clinique-et-translationnelle-soutenus-par-l%e2%80%99inca-et-la-dgos/feed 0 http://www.mypharma-editions.com/melanome-vers-de-nouvelles-strategies-therapeutiques http://www.mypharma-editions.com/melanome-vers-de-nouvelles-strategies-therapeutiques#comments Tue, 07 Jun 2011 15:39:25 +0000 morgdave http://www.mypharma-editions.com/?p=19648 http://www.mypharma-editions.com/melanome-vers-de-nouvelles-strategies-therapeutiques/feed 0 http://www.mypharma-editions.com/cancer-de-nouvelles-donnees-valident-le-developpement-d%e2%80%99iniparib-de-sanofi http://www.mypharma-editions.com/cancer-de-nouvelles-donnees-valident-le-developpement-d%e2%80%99iniparib-de-sanofi#comments Tue, 07 Jun 2011 08:22:32 +0000 morgdave http://www.mypharma-editions.com/?p=19637 http://www.mypharma-editions.com/cancer-de-nouvelles-donnees-valident-le-developpement-d%e2%80%99iniparib-de-sanofi/feed 0 http://www.mypharma-editions.com/cancer-du-sein-aromasine%c2%ae-reduit-de-65-le-risque-chez-les-femmes-menopausees-a-risque-eleve http://www.mypharma-editions.com/cancer-du-sein-aromasine%c2%ae-reduit-de-65-le-risque-chez-les-femmes-menopausees-a-risque-eleve#comments Mon, 06 Jun 2011 11:36:36 +0000 morgdave http://www.mypharma-editions.com/?p=19607 http://www.mypharma-editions.com/cancer-du-sein-aromasine%c2%ae-reduit-de-65-le-risque-chez-les-femmes-menopausees-a-risque-eleve/feed 0 http://www.mypharma-editions.com/sanofi-et-regeneron-donnees-positives-pour-zaltrap%e2%84%a2-dans-le-cancer-colorectal-metastatique http://www.mypharma-editions.com/sanofi-et-regeneron-donnees-positives-pour-zaltrap%e2%84%a2-dans-le-cancer-colorectal-metastatique#comments Mon, 06 Jun 2011 07:06:10 +0000 morgdave http://www.mypharma-editions.com/?p=19591 http://www.mypharma-editions.com/sanofi-et-regeneron-donnees-positives-pour-zaltrap%e2%84%a2-dans-le-cancer-colorectal-metastatique/feed 0 http://www.mypharma-editions.com/roche-le-vemurafenib-ameliore-la-survie-lors-de-melanome-metastatique-a-mutations-braf-v600 http://www.mypharma-editions.com/roche-le-vemurafenib-ameliore-la-survie-lors-de-melanome-metastatique-a-mutations-braf-v600#comments Mon, 06 Jun 2011 06:55:58 +0000 morgdave http://www.mypharma-editions.com/?p=19589 http://www.mypharma-editions.com/roche-le-vemurafenib-ameliore-la-survie-lors-de-melanome-metastatique-a-mutations-braf-v600/feed 0 http://www.mypharma-editions.com/sanofi-la-semuloparine-reduit-de-64-le-risque-de-thrombose-veineuse-chez-les-patients-cancereux http://www.mypharma-editions.com/sanofi-la-semuloparine-reduit-de-64-le-risque-de-thrombose-veineuse-chez-les-patients-cancereux#comments Sun, 05 Jun 2011 10:01:26 +0000 morgdave http://www.mypharma-editions.com/?p=19579 http://www.mypharma-editions.com/sanofi-la-semuloparine-reduit-de-64-le-risque-de-thrombose-veineuse-chez-les-patients-cancereux/feed 0 http://www.mypharma-editions.com/roche-avastin-reduit-de-moitie-le-risque-de-progression-du-cancer-de-l%e2%80%99ovaire-recurrent http://www.mypharma-editions.com/roche-avastin-reduit-de-moitie-le-risque-de-progression-du-cancer-de-l%e2%80%99ovaire-recurrent#comments Sun, 05 Jun 2011 09:47:44 +0000 morgdave http://www.mypharma-editions.com/?p=19577 http://www.mypharma-editions.com/roche-avastin-reduit-de-moitie-le-risque-de-progression-du-cancer-de-l%e2%80%99ovaire-recurrent/feed 0 http://www.mypharma-editions.com/roche-resultats-positifs-pour-tarceva-dans-une-forme-genetiquement-distincte-de-cancer-du-poumon http://www.mypharma-editions.com/roche-resultats-positifs-pour-tarceva-dans-une-forme-genetiquement-distincte-de-cancer-du-poumon#comments Fri, 03 Jun 2011 07:54:26 +0000 morgdave http://www.mypharma-editions.com/?p=19560 http://www.mypharma-editions.com/roche-resultats-positifs-pour-tarceva-dans-une-forme-genetiquement-distincte-de-cancer-du-poumon/feed 0 http://www.mypharma-editions.com/cancer-de-la-peau-accord-de-recherche-entre-roche-et-bristol-myers-squibb-sur-un-traitement-combine http://www.mypharma-editions.com/cancer-de-la-peau-accord-de-recherche-entre-roche-et-bristol-myers-squibb-sur-un-traitement-combine#comments Thu, 02 Jun 2011 12:44:15 +0000 morgdave http://www.mypharma-editions.com/?p=19546 http://www.mypharma-editions.com/cancer-de-la-peau-accord-de-recherche-entre-roche-et-bristol-myers-squibb-sur-un-traitement-combine/feed 0 http://www.mypharma-editions.com/le-telephone-portable-cancerogene-l%e2%80%99oms-repond-%c2%ab-peut-etre-%c2%bb%e2%80%a6 http://www.mypharma-editions.com/le-telephone-portable-cancerogene-l%e2%80%99oms-repond-%c2%ab-peut-etre-%c2%bb%e2%80%a6#comments Wed, 01 Jun 2011 10:01:55 +0000 morgdave http://www.mypharma-editions.com/?p=19534 http://www.mypharma-editions.com/le-telephone-portable-cancerogene-l%e2%80%99oms-repond-%c2%ab-peut-etre-%c2%bb%e2%80%a6/feed 0 http://www.mypharma-editions.com/linca-labellise-les-sept-canceropoles http://www.mypharma-editions.com/linca-labellise-les-sept-canceropoles#comments Wed, 01 Jun 2011 09:31:15 +0000 morgdave http://www.mypharma-editions.com/?p=19531 http://www.mypharma-editions.com/linca-labellise-les-sept-canceropoles/feed 0 http://www.mypharma-editions.com/hybrigenics-presentera-les-resultats-de-l%e2%80%99inecalcitol-au-congres-de-la-societe-americaine-d%e2%80%99oncologie-clinique http://www.mypharma-editions.com/hybrigenics-presentera-les-resultats-de-l%e2%80%99inecalcitol-au-congres-de-la-societe-americaine-d%e2%80%99oncologie-clinique#comments Wed, 01 Jun 2011 09:19:52 +0000 morgdave http://www.mypharma-editions.com/?p=19528 http://www.mypharma-editions.com/hybrigenics-presentera-les-resultats-de-l%e2%80%99inecalcitol-au-congres-de-la-societe-americaine-d%e2%80%99oncologie-clinique/feed 0 http://www.mypharma-editions.com/agnes-buzyn-nommee-presidente-de-l%e2%80%99inca http://www.mypharma-editions.com/agnes-buzyn-nommee-presidente-de-l%e2%80%99inca#comments Mon, 30 May 2011 08:29:03 +0000 morgdave http://www.mypharma-editions.com/?p=19463 http://www.mypharma-editions.com/agnes-buzyn-nommee-presidente-de-l%e2%80%99inca/feed 0